An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The results were impressive. PAC-MANN correctly identified pancreatic cancer in 98% of cases and was able to detect ...